HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) All Versions of this Article: db08-0182v1 db08-0182v2 57/11/3078    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Google Scholar Articles by Rinnov Nielsen, A. Articles by Klarlund Pedersen, B. PubMed PubMed Citation Articles by Rinnov Nielsen, A. Articles by Klarlund Pedersen, B. Social Bookmarking                What's this?

Plasma YKL-40 - a BMI-independent marker of type 2 diabetes

¹The Centre of Inflammation and Metabolism, Department of Infectious Diseases and CMRC, Rigshospitalet, Faculty of Health Sciences, University of Copenhagen, Denmark
²Department of Rheumatology, Herlev Hospital, University of Copenhagen, Denmark

Objective.: YKL-40 is produced by macrophages and plasma YKL-40 is elevated in patients with diseases characterized by inflammation. In the present study, YKL-40 was examined in relation to obesity, inflammation, and type 2 diabetes mellitus (T2DM).

Research Design and Methods.: Plasma YKL-40 and adipose tissue YKL-40 mRNA levels were investigated in 199 subjects divided into four groups depending on the presence or absence of T2DM and obesity. In addition, plasma YKL-40 was examined in healthy subjects during a hyperglycaemic clamp, where the plasma glucose level was kept at 15 mM for 3 hours and during a hyperinsulinaemic euglycaemic clamp.

Results.: Patients with T2DM had higher plasma YKL-40 (76.7 vs. 45.1 ng/ml, p = 0.0001), but not higher expression in adipose tissue YKL-40 mRNA (1.20 vs. 0.98, p = 0.2), compared to subjects with a normal glucose tolerance. Within the groups with normal glucose tolerance and T2DM, obesity subgroups showed no difference with respect to either plasma YKL-40 or adipose tissue YKL-40 mRNA levels. Multivariate regression analysis showed that plasma YKL-40 was associated with fasting plasma glucose (β = 0.5, p = 0.0014) and plasma IL-6 (β = 0.2, p = 0.0303). Plasma YKL-40 was not related to parameters of obesity. There were no changes in plasma YKL-40 in healthy subjects during either hyperglycaemic or hyperinsulinaemic euglycaemic clamps.

Conclusions.: Plasma YKL-40 was identified as an obesity-independent marker of T2DM, related to fasting plasma glucose and plasma IL-6 levels.

Key Words: CHI3L1 • YKL-40 • type 2 diabetes • macrophage • obesity

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?